Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Citius Pharmaceuticals, Inc. (CTXR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| MCGRATH DENNIS M (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.42, valued at
$106.5k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| HOLUBIAK MYRON Z (Vice Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.25, valued at
$500k
|
|
| 10/06/2022 |
4
| Mazur Leonard L (Executive Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 550,000 options to buy
@ $1.25, valued at
$687.5k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| SAFIR HOWARD (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.25, valued at
$93.8k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2021 |
4
| HOLUBIAK MYRON Z (President and CEO) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 650,000 options to buy
@ $2.04, valued at
$1.3M
Granted 15,000 options to buy
@ $2.04, valued at
$30.6k
|
|
| 10/13/2021 |
4
| Mazur Leonard L (Executive Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 650,000 options to buy
@ $2.04, valued at
$1.3M
|
|
| 10/13/2021 |
4
| Webb Carol (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.04, valued at
$153k
|
|
| 10/13/2021 |
4
| Bartushak Jaime (CFO) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2.04, valued at
$612k
|
|
| 10/13/2021 |
4
| SAFIR HOWARD (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.04, valued at
$153k
|
|
| 10/13/2021 |
4
| Holuka Eugene Myron (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.04, valued at
$153k
|
|
| 10/13/2021 |
4
| Dutia Suren G (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.04, valued at
$153k
|
|
| 10/13/2021 |
4
| Czuczman Myron (Chief Medical Officer) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2.04, valued at
$612k
|
|
| 10/13/2021 |
4
| Kane William (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.04, valued at
$153k
|
|
| 07/26/2021 |
4
| Kane William (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2, valued at
$30k
|
|
| 07/26/2021 |
4
| Dutia Suren G (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2, valued at
$30k
|
|
| 07/26/2021 |
4
| HOLUBIAK MYRON Z (President and CEO) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2, valued at
$600k
Granted 10,000 options to buy
@ $2, valued at
$20k
|
|
| 07/26/2021 |
4
| Mazur Leonard L (Executive Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2, valued at
$600k
|
|
| 07/26/2021 |
4
| Bartushak Jaime (CFO) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2, valued at
$200k
|
|
| 07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| Holuka Eugene Myron (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2, valued at
$30k
|
|
|
|
|